Cephalon Option To Buy Biologics Firm Ception Gets The Ball Rolling For 2009, CEO Says

Look for Cephalon to “roll up” more assets this year while the market is good, CEO Baldino says at J.P. Morgan.

More from Archive

More from Pink Sheet